Marijuana Use More Common Among Adults with Medical Conditions


A new study shows that approximately one-quarter of adults aged 18-34 years old with a medical condition have used marijuna in the past month.

Hongying Dai, PhD

Hongying Dai, PhD

More than 1 in 10 US adults aged 18-34 years old with a medical condition smoke marijuana on a daily basis, according to a new survey.

An assessment of data from the 2016 and 2017 Behavioral Risk Factor Surveillance System telephone surveys found adults with medical conditions were more likely to report current marijuana use than those without conditions. The study—which also found correlations between decreasing overall marijuana use and increasing adult age—shows a need to better interpret how patients are using marijuana relative to possible medical conditions.

Hongying Dai, PhD, of the Nebraska Medical Center; and Kimber P. Richter, PhD, of the University of Kansas Medical Center, observed the prevalence and pattern of marijuana use among surveyed adults. Adults were stratified by whether they did or did not have medical conditions and their sociodemographic group.

Observing the past month and daily marijuana use, Dai and Richter sought to understand the associations between marijuana use, and the types and rate of medical conditions users have.

Their study sample included 169,036 survey participants, with 56.7% (n= 95,780) being female, and 61.7% (n= 104,228) having a medical condition. Participants were separated by age groups: 18-34 years; 35-54 years; and ≥55 years.

Adults with medical conditions were more likely to report marijuana use at each age category (18-34 years adjusted odds ratio [OR], 1.8 [95% CI, 1.5-2.1]; 35-54 years adjusted OR, 1.4 [95% CI, 1.2-1.7]; ≥55 years adjusted OR, 1.6 [95% CI, 1.3-2.0]).

Overall, three-fourths (77.5%; 95% CI, 74.7-80.3) of all participants reported smoking as their primary method of marijuana administration. A similar rate of administering marijuana via smoking—or more—was observed in participants who suffer from coronary artery disease (88.6%), stroke (88.3%), heart attack (88.3%), chronic obstructive pulmonary disease (82.5%), diabetes (80.6%), depression (79.2%), and asthma (75.7%).

Among the 18-24 year old age group with medical conditions, 25.2% reported use of marijuana within the last month, and 11.2% reported using it on a daily basis. The prevalence of marijuana use among the youngest adults compared to adults aged 65 years and older among those with medical conditions was more than ten-fold (2.4%).

Investigators observed that the perceived harm and benefits of marijuana use may vary widely across the age groups, as previous studies have shown older adults are more likely to perceive the drug as addictive and harmful to health.

“However, public opinions on marijuana use have been softening, and fewer older adults are reporting disapproval of marijuana use,” Dai and Richter wrote. “The increase in public acceptance of marijuana use could lead to older adults to start using marijuana for medical conditions.”

Almost one-half (45.5%) of people with medical conditions who use marijuana said they do so for medical purposes—a greater rate than marijuana users without medical conditions. That said, investigators reiterated the point that the majority were not strictly seeking therapeutic benefit. They noted the risks for adverse health outcomes associated with the drug—including worsened respiratory symptoms, impaired short-term memory, and increased risk of psychiatry illness and addiction.

“Patients who are using marijuana for a medical condition should be informed of evidence of efficacy and adverse outcomes for that condition,” they wrote. “Those who are using marijuana recreationally should also be informed of the adverse health outcomes and benefits of marijuana consumption.”

Dai and Richter called for greater surveillance of marijuana use among physician’s patients, and advised they adopt means by which to consistently address marijuana use, its benefits, and its risks.

The burden is not strictly on physicians to better inform patients, however.

“Policy makers should monitor health claims made by merchants and perceptions of benefits among consumers to ensure that patients—especially those with existing medical conditions—understand the evolving knowledge base regarding the risks and benefits of marijuana consumption,” they concluded.

The study, “A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2016-2017,” was published online in JAMA Network Open.

Related Videos
Video 4 - "Mavacamten in oHCM: Navigating the REMS Program for Safe, Optimal Outcomes "
Video 3 - "Aligning With 2023 ESC Guidelines in oHCM Treatment"
Robert Rosenson, MD | Credit: Cura Foundation
Why Are Adult ADHD Cases Climbing?
A panel of 4 experts on asthma
A panel of 4 experts on asthma
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Robert Rosenson, MD | Credit: Cura Foundation
A panel of 5 experts on Cushing's syndrome
© 2024 MJH Life Sciences

All rights reserved.